Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease

Nature Reviews Immunology

Volumn 16, Issue 3, 2016, Pages 149-163

  Dupage, Michel ^a   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

CD4+ T LYMPHOCYTE; CELL ENERGY; CELL METABOLISM; CELL PLASTICITY; CYTOSOL; DNA METHYLATION; DNA MODIFICATION; DNA SYNTHESIS INHIBITION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HETEROCHROMATIN; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOTHERAPY; INTRACELLULAR SIGNALING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; PROCEDURES; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOTHERAPY; T-LYMPHOCYTE SUBSETS;

EID: 84959539367     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2015.18     Document Type: Review

References (203)

1. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A, & Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
2. Del Prete G. F, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88, 346-350 (1991).
3. Abbas A. K., Murphy K. M, & Sher A. Functional diversity of helper T lymphocytes. Nature. 383, 787-793 (1996).
4. Burkett P. R., Meyer zu Horste G, & Kuchroo V. K. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J. Clin. Invest. 125, 2211-2219 (2015).
5. Schmitt E., Klein M, & Bopp T. Th9 cells, new players in adaptive immunity. Trends Immunol. 35, 61-68 (2014).
6. Crotty S. T. Follicular helper cell differentiation, function, and roles in disease. Immunity. 41, 529-542 (2014).
7. Wing J. B, & Sakaguchi S. Multiple Treg suppressive modules and their adaptability. Front. Immunol. 3, 178 (2012).
8. Wilson C. B., Rowell E, & Sekimata M. Epigenetic control of T helper-cell differentiation. Nat. Rev. Immunol. 9, 91-105 (2009).
9. Zhou L., Chong M. M. W, & Littman D. R. Plasticity of CD4+ T cell lineage differentiation. Immunity. 30, 646-655 (2009).
10. O'Shea J. J, & Paul W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science. 327, 1098-1102 (2010).
11. Murphy K. M, & Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 11, 674-680 (2010).
12. Bluestone J. A., Mackay C. R., O'Shea J. J, & Stockinger B. The functional plasticity of T cell subsets. Nat. Rev. Immunol. 9, 811-816 (2009).
13. Wang Y. H, et al. A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL 17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 207, 2479-2491 (2010).
14. Dominguez-Villar M., Baecher-Allan C. M, & Hafler D. A. Identification of T helper type 1 like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673-675 (2011).
15. Malmhäll C, et al. Immunophenotyping of circulating T helper cells argues for multiple functions and plasticity of T cells in vivo in humans - possible role in asthma. PLoS ONE 7, e40012 (2012).
16. Perez V. L., Lederer J. A., Lichtman A. H, & Abbas A. K. Stability of Th1 and Th2 populations. Int. Immunol. 7, 869-875 (1995).
17. Koenen H. J. P. M, et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL 17 producing cells. Blood. 112, 2340-2352 (2008).
18. Yang X. O, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 29, 44-56 (2008).
19. Lee Y. K, et al. Late developmental plasticity in the T helper 17 lineage. Immunity. 30, 92-107 (2009).
20. Lohning M, et al. Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J. Exp. Med. 205, 53-61 (2008).
21. Bending D, et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1 like cells in NOD/SCID recipient mice. J. Clin. Invest. 119, 565-572 (2009).
22. Jager A., Dardalhon V., Sobel R. A., Bettelli E, & Kuchroo V. K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177 (2009).
23. Lüthje K, et al. The development and fate of follicular helper T cells defined by an IL 21 reporter mouse. Nat. Immunol. 13, 491-498 (2012).
24. Panzer M, et al. Rapid in vivo conversion of effector T cells into Th2 Cells during helminth infection. J. Immunol. 188, 615-623 (2012).
25. Harbour S. N., Maynard C. L., Zindl C. L., Schoeb T. R, & Weaver C. T. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc. Natl Acad. Sci. USA. 112, 7061-7066 (2015).
26. Zhou X, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007 (2009).
27. Hirota K, et al. Fate mapping of IL 17 producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263 (2011).
28. Wilhelm C, et al. An IL 9 fate reporter demonstrates the induction of an innate IL 9 response in lung inflammation. Nat. Immunol. 12, 1071-1077 (2011).
29. Ahlfors H, et al. IL 22 fate reporter reveals origin and control of IL 22 production in homeostasis and infection. J. Immunol. 193, 4602-4613 (2014).
30. Becattini S, et al. T cell immunity. Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines. Science. 347, 400-406 (2015).
31. Han A., Glanville J., Hansmann L, & Davis M. M. Linking T cell receptor sequence to functional phenotype at the single-cell level. Nat. Biotechnol. 32, 684-692 (2014).
32. Wang C, et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell. 163, 1413-1427 (2015).
33. Gaublomme J. T, et al. Single-Cell genomics unveils critical regulators of Th17 cell pathogenicity. Cell. 163, 1400-1412 (2015).
34. O'Shea J. J, et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu. Rev. Med. 66, 311-328 (2015).
35. Hegazy A. N, et al. Interferons direct Th2 cell reprogramming to generate a stable GATA 3+T bet+ cell subset with combined Th2 and Th1 cell functions. Immunity. 32, 116-128 (2010).
36. Veldhoen M, et al. Transforming growth factor â 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9 producing subset. Nat. Immunol. 9, 1341-1346 (2008).
37. Lu K. T, et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity. 35, 622-632 (2011).
38. Knosp C. A, & Johnston J. A. Regulation of CD4+ T cell polarization by suppressor of cytokine signalling proteins. Immunology. 135, 101-111 (2012).
39. Bettelli E, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441, 235-238 (2006).
40. Zhou L, et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing ROR?t function. Nature. 453, 236-240 (2008).
41. Gagliani N, et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature. 523, 221-225 (2015).
42. Stumhofer J. S, et al. Interleukins 27 and 6 induce STAT3 mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363-1371 (2007).
43. Apetoh L, et al. The aryl hydrocarbon receptor interacts with c Maf to promote the differentiation of type 1 regulatory T cells induced by IL 27. Nat. Immunol. 11, 854-861 (2010).
44. Hunter C. A, & Kastelein R. Interleukin 27: balancing protective and pathological immunity. Immunity. 37, 960-969 (2012).
45. Laurence A, et al. STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease. Immunity. 37, 209-222 (2012).
46. Oldenhove G, et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity. 31, 772-786 (2009).
47. Koch M. A, et al. The transcription factor T bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602 (2009).
48. McClymont S. A, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918-3926 (2011).
49. Campbell D. J, & Koch M. A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11, 119-130 (2011).
50. Feng T., Cao A. T., Weaver C. T., Elson C. O, & Cong Y. Interleukin 12 converts Foxp3+ regulatory T cells to interferon-?-producing Foxp3+ T cells that inhibit colitis. Gastroenterology. 140, 2031-2043 (2011).
51. Fuhrman C. A, et al. Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226. J. Immunol. 195, 145-155 (2015).
52. Tang Q, et al. Central role of defective interleukin 2 production in the triggering of islet autoimmune destruction. Immunity. 28, 687-697 (2008).
53. Feng Y, et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell. 158, 749-763 (2014).
54. Klatzmann D, & Abbas A. K. The promise of low-dose interleukin 2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283-294 (2015).
55. van Panhuys N., Klauschen F, & Germain R. N. T cell-receptor-dependent signal intensity dominantly controls CD4+ T cell polarization in vivo. Immunity. 41, 63-74 (2014).
56. Yamane H, & Paul W. E. Early signaling events that underlie fate decisions of naive CD4+ T cells toward distinct T helper cell subsets. Immunol. Rev. 252, 12-23 (2013).
57. Fazilleau N., McHeyzer-Williams L. J., Rosen H, & McHeyzer-Williams M. G. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10, 375-384 (2009).
58. Tubo N. J, et al. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell. 153, 785-796 (2013).
59. Sauer S, et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl Acad. Sci. USA. 105, 7797-7802 (2008).
60. Gottschalk R. A., Corse E, & Allison J. P. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207, 1701-1711 (2010).
61. Hsieh C. S., Lee H. M, & Lio C. W. Selection of regulatory T cells in the thymus. Nat. Rev. Immunol. 12, 157-167 (2012).
62. Ohkura N, et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity. 37, 785-799 (2012).
63. Nagaoka M., Hatta Y., Kawaoka Y, & Malherbe L. P. Antigen signal strength during priming determines effector CD4 T cell function and antigen sensitivity during influenza virus challenge. J. Immunol. 193, 2812-2820 (2014).
64. Ahmadzadeh M, & Farber D. L. Functional plasticity of an antigen-specific memory CD4 T cell population. Proc. Natl Acad. Sci. USA. 99, 11802-11807 (2002).
65. Martinez-Sanchez M. E., Mendoza L., Villarreal C, & Alvarez-Buylla E. R. A. Minimal regulatory network of extrinsic and intrinsic factors recovers observed patterns of CD4+ T cell differentiation and plasticity. PLoS Comput. Biol. 11, e1004324 (2015).
66. Moran A. E, et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208, 1279-1289 (2011).
67. Levine A. G., Arvey A., Jin W, & Rudensky A. Y. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15, 1070-1078 (2014).
68. Vahl J. C, et al. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity. 41, 722-736 (2014).
69. Tang Q, et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+ CD25+ regulatory T cells. J. Immunol. 171, 3348 (2003).
70. Zhang R, et al. An obligate cell-intrinsic function for CD28 in Tregs. J. Clin. Invest. 123, 580-593 (2013).
71. Bailey-Bucktrout S. L, et al. Self-Antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity. 39, 949-962 (2013).
72. Gratz I. K, et al. Cutting edge: self-Antigen controls the balance between effector and regulatory T cells in peripheral tissues. J. Immunol. 192, 1351-1355 (2014).
73. Laky K., Evans S., Perez-Diez A, & Fowlkes B. J. Notch signaling regulates antigen sensitivity of naive CD4+ T cells by tuning co stimulation. Immunity. 42, 80-94 (2015).
74. Bensinger S. J, et al. Distinct IL 2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172, 5287-5296 (2004).
75. Buckler J. L., Liu X, & Turka L. A. Regulation of T cell responses by PTEN. Immunol. Rev. 224, 239-248 (2008).
76. Crellin N. K., Garcia R. V, & Levings M. K. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood. 109, 2014-2022 (2007).
77. Walsh P. T, et al. PTEN inhibits IL 2 receptor-mediated expansion of CD4+ CD25+ Tregs. J. Clin. Invest. 116, 2521-2531 (2006).
78. Patterson S. J, et al. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J. Immunol. 186, 5533-5537 (2011).
79. Huynh A, et al. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188-196 (2015).
80. Shrestha S, et al. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat. Immunol. 16, 178-187 (2015).
81. Ouyang W, et al. Novel Foxo1 dependent transcriptional programs control Treg cell function. Nature. 491, 554-559 (2012).
82. Delgoffe G. M, et al. Stability and function of regulatory T cells is maintained by a neuropilin 1 semaphorin 4a axis. Nature. 501, 252-256 (2013).
83. Yang K, et al. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor mTORC1 mediated metabolic reprogramming. Immunity. 39, 1043-1056 (2013).
84. Delgoffe G. M, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295-303 (2011).
85. Delgoffe G. M, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 30, 832-844 (2009).
86. Lee K, et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity. 32, 743-753 (2010).
87. Kurebayashi Y, et al. PI3K Akt mTORC1 S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of ROR?. Cell Rep. 1, 360-373 (2012).
88. Zeng H, et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature. 499, 485-490 (2013).
89. Yurchenko E, et al. Inflammation-driven reprogramming of CD4+Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS ONE 7, e35572 (2012).
90. Park Y, et al. TSC1 regulates the balance between effector and regulatory T cells. J. Clin. Invest. 123, 5165-5178 (2013).
91. Miskov-Zivanov N., Turner M. S., Kane L. P., Morel P. A, & Faeder J. R. The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Sci. Signal. 6, ra97 (2013).
92. Pearce E. L., Poffenberger M. C., Chang C. H, & Jones R. G. Fueling immunity: insights into metabolism and lymphocyte function. Science. 342, 1242454-1242454 (2013).
93. Frauwirth K. A, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity. 16, 769-777 (2002).
94. Macintyre A. N, et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell. Metab. 20, 61-72 (2014).
95. Basu S., Hubbard B, & Shevach E. M. Foxp3 mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells. J. Leukocyte Biol. 97, 279-283 (2015).
96. Michalek R. D, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299-3303 (2011).
97. Gerriets V. A, et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194-207 (2014).
98. Furusawa Y, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 504, 446-450 (2013).
99. Arpaia N, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation. Nature. 504, 451-455 (2013).
100. Klysz D, et al. Glutamine-dependent α ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Sci. Signal. 8, ra97 (2015).
101. Nakamura H, et al. TCR engagement increases hypoxia-inducible factor 1 protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J. Immunol. 174, 7592-7599 (2005).
102. Shi L. Z, et al. HIF1α dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376 (2011).
103. Lee J. H., Elly C., Park Y, & Liu Y. C. E3 ubiquitin ligase VHL regulates hypoxia-inducible factor 1α to maintain regulatory T cell stability and suppressive capacity. Immunity. 42, 1062-1074 (2015).
104. Dang E. V, et Al. Control of TH17/Treg Balance by Hypoxia-inducible Factor 1. Cell. 146, 772-784 (2011).
105. Oestreich K. J, et al. Bcl 6 directly represses the gene program of the glycolysis pathway. Nat. Immunol. 15, 957-964 (2014).
106. Tamas P. Regulation of the energy sensor AMP-Activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J. Exp. Med. 203, 1665-1670 (2006).
107. MacIver N. J, et al. The liver kinase B1 is a central regulator of T cell development, activation, and metabolism. J. Immunol. 187, 4187-4198 (2011).
108. Blagih J, et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity. 42, 41-54 (2015).
109. Faubert B, et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell. Metab. 17, 113-124 (2013).
110. Chang C. H, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 153, 1239-1251 (2013).
111. Berod L, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327-1333 (2014).
112. Williams C. L, et al. STAT4 and T bet are required for the plasticity of IFN ? expression across Th2 ontogeny and influence changes in Ifng promoter DNA methylation. J. Immunol. 191, 678-687 (2013).
113. Vahedi G, et al. STATs shape the active enhancer landscape of T cell populations. Cell. 151, 981-993 (2012).
114. Goswami R, et al. STAT6 dependent regulation of Th9 development. J. Immunol. 188, 968-975 (2012).
115. Samstein R. M, et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell. 151, 153-166 (2012).
116. Oestreich K. J, & Weinmann A. S. Master regulators or lineage-specifying?. Changing views on CD4+ T cell transcription factors. Nat. Rev. Immunol. 12, 799-804 (2012).
117. Wei G, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 30, 155-167 (2009).
118. Shih H. Y, et al. Transcriptional and epigenetic networks of helper T and innate lymphoid cells. Immunol. Rev. 261, 23-49 (2014).
119. Fu W, et al. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nat. Immunol. 13, 972-980 (2012).
120. Lee T. I, & Young R. A. Transcriptional regulation and its misregulation in disease. Cell. 152, 1237-1251 (2013).
121. Roychoudhuri R, et al. BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. Nature. 498, 506-510 (2013).
122. Wang Y, et al. The transcription factors T bet and Runx are required for the ontogeny of pathogenic interferon-? producing T helper 17 cells. Immunity. 40, 355-366 (2014).
123. Sekiya T, et al. Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells. J. Exp. Med. 212, 1623-1640 (2015).
124. Brown C. C, et al. Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program. Immunity. 42, 499-511 (2015).
125. Park B. V, & Pan F. The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases. Cell. Mol. Immunol. 12, 533-542 (2015).
126. Bird J, et al. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9, 229-237 (1998).
127. Agarwal S, & Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 9, 765-775 (1998).
128. Grogan J. L, et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity. 14, 205-215 (2001).
129. Avni O, et al. TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3, 643-651 (2002).
130. Hojfeldt J. W., Agger K, & Helin K. Histone lysine demethylases as targets for anticancer therapy. Nat. Rev. Drug Discov. 12, 917-930 (2013).
131. Pastor W. A., Aravind L, & Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14, 341-356 (2013).
132. Zhang F. T helper type 1 specific Brg1 recruitment and remodeling of nucleosomes positioned at the IFN ? promoter are Stat4 dependent. J. Exp. Med. 203, 1493-1505 (2006).
133. Schones D. E, et al. Dynamic regulation of nucleosome positioning in the human genome. Cell. 132, 887-898 (2008).
134. Wang Z, et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell. 138, 1019-1031 (2009).
135. Ichiyama K, et al. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T Cells. Immunity. 42, 613-626 (2015).
136. Onodera A, & Nakayama T. Epigenetics of T cells regulated by Polycomb/Trithorax molecules. Trends Mol. Med. 21, 330-340 (2015).
137. Miller S. A., Huang A. C., Miazgowicz M. M., Brassil M. M, & Weinmann A. S. Coordinated but physically separable interaction with H3K27 demethylase and H3K4 methyltransferase activities are required for T box protein-mediated activation of developmental gene expression. Genes Dev. 22, 2980-2993 (2008).
138. Bettini M. L, et al. Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity. 36, 717-730 (2012).
139. Wang L, et al. Mbd2 promotes Foxp3 demethylation and T regulatory-cell function. Mol. Cell. Biol. 33, 4106-4115 (2013).
140. Yang R, et al. Hydrogen sulfide promotes Tet1- And Tet2 mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis. Immunity. 43, 251-263 (2015).
141. Liu Y, et al. Two histone/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T regulatory cell development and function. Mol. Cell. Biol. 34, 3993-4007 (2014).
142. Yamashita M, et al. Crucial role of MLL for the maintenance of memory T helper type 2 cell responses. Immunity. 24, 611-622 (2006).
143. Collier S. P., Collins P. L., Williams C. L., Boothby M. R, & Aune T. M. Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J. Immunol. 189, 2084-2088 (2012).
144. Gomez J. A, et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-? locus. Cell. 152, 743-754 (2013).
145. Satpathy A. T, & Chang H. Y. Long noncoding RNA in hematopoiesis and immunity. Immunity. 42, 792-804 (2015).
146. van den Ham H. J, & de Boer R. J. Cell division curtails helper phenotype plasticity and expedites helper T cell differentiation. Immunol. Cell Biol. 90, 860-868 (2012).
147. Thomas R. M., Gamper C. J., Ladle B. H., Powell J. D, & Wells A. D. De novo DNA methylation is required to restrict T helper lineage plasticity. J. Biol. Chem. 287, 22900-22909 (2012).
148. Liu B., Tahk S., Yee K. M., Fan G, & Shuai K. The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science. 330, 521-525 (2010).
149. Busslinger M, & Tarakhovsky A. Epigenetic control of immunity. Cold Spring Harb. Perspect. Biol. 6, a019307 (2014).
150. Wang L, et al. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3. J. Clin. Invest. 125, 1111-1123 (2015).
151. Arvey A, et al. Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 15, 580-587 (2014).
152. DuPage M, et al. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation. Immunity. 42, 227-238 (2015).
153. Tumes D. J, et al. The polycomb protein Ezh2 regulates differentiation and plasticity of CD4+ T helper type 1 and type 2 cells. Immunity. 39, 819-832 (2013).
154. Zhang Y, et al. The polycomb repressive complex 2 governs life and death of peripheral T cells. Blood. 124, 737-749 (2014).
155. Escobar T. M, et al. miR 155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity. 40, 865-879 (2014).
156. Li Q, et al. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T cell differentiation. Nat. Commun. 5, 5780 (2014).
157. Allan R. S, et al. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature. 487, 249-253 (2012).
158. Antignano F, et al. Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation. J. Clin. Invest. 124, 1945-1955 (2014).
159. Huang C, et al. Cutting edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28. J. Immunol. 190, 4470-4473 (2013).
160. Xu K, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science. 338, 1465-1469 (2012).
161. Kim E, et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell. 23, 839-852 (2013).
162. Badeaux A. I, & Shi Y. Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14, 211-224 (2013).
163. Baumjohann D, & Ansel K. M. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat. Rev. Immunol. 13, 666-678 (2013).
164. Long S. A, et al. Defects in IL 2R signaling contribute to diminished maintenance of FOXP3 expression in CD4+CD25+ regulatory T cells of type 1 diabetic subjects. Diabetes. 59, 407-415 (2010).
165. Carbone F, et al. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20, 69-74 (2013).
166. Bending D, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J. Immunol. 193, 2699-2708 (2014).
167. Rivas M. N, et al. Regulatory T cell reprogramming toward a Th2 cell-like lineage impairs oral tolerance and promotes food allergy. Immunity. 42, 512-523 (2015).
168. Komatsu N, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62-68 (2014).
169. Blatner N. R, et al. Expression of ROR?t marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl Med. 4, 164ra159 (2012).
170. McGeachy M. J, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17 producing effector T helper cells in vivo. Nat. Immunol. 10, 314-324 (2009).
171. Hirota K, et al. Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell- dependent IgA responses. Nat. Immunol. 14, 372-379 (2013).
172. Araya N, et al. HTLV 1 induces a Th1 like state in CD4+CCR4+ T cells. J. Clin. Invest. 124, 3431-3442 (2014).
173. Bluestone J. A., Crellin N, & Trotta E. IL 2: change structure change function. Immunity. 42, 779-781 (2015).
174. Herold K. C, et al. Anti CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698 (2002).
175. Penaranda C., Tang Q, & Bluestone J. A. Anti CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells. J. Immunol. 187, 2015-2022 (2011).
176. Littman D. R. Releasing the brakes on cancer immunotherapy. Cell. 162, 1186-1190 (2015).
177. Long S. A, et al. Rapamycin/IL 2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes. 61, 2340-2348 (2012).
178. Ali K, et al. Inactivation of PI(3)K p110d breaks regulatory T cell-mediated immune tolerance to cancer. Nature. 510, 407-411 (2014).
179. Putnam A. L, et al. Expansion of human regulatory T cells from patients with type 1 diabetes. Diabetes. 58, 652-662 (2009).
180. Fischbach M. A., Bluestone J. A, & Lim W. A. Cell-based therapeutics: the next pillar of medicine. Sci. Transl Med. 5, 179ps177 (2013).
181. Guedan S, et al. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells. Blood. 124, 1070-1080 (2014).
182. Yin Y, et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl Med. 7, 274ra218 (2015).
183. Chen Z, et al. The Ubiquitin Ligase Stub1 Negatively Modulates Regulatory T Cell Suppressive Activity by Promoting Degradation of the Transcription Factor Foxp3. Immunity. 39, 272-285 (2013).
184. Yang J, et al. Cutting edge: ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing ROR?t. J. Immunol. 194, 4094-4097 (2015).
185. Jang E. J., Park H. R., Hong J. H, & Hwang E. S. Lysine 313 of T box is crucial for modulation of protein stability, DNA binding, and threonine phosphorylation of T bet. J. Immunol. 190, 5764-5770 (2013).
186. Beier U. H, et al. Sirtuin 1 targeting promotes Foxp3+ T regulatory cell function and prolongs allograft survival. Mol. Cell. Biol. 31, 1022-1029 (2011).
187. Kwon H. S, et al. Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells. J. Immunol. 188, 2712-2721 (2012).
188. Lim H. W, et al. SIRT1 deacetylates ROR?t and enhances Th17 cell generation. J. Exp. Med. 212, 607-617 (2015).
189. Peng D, et al. Epigenetic silencing of TH1 type chemokines shapes tumour immunity and immunotherapy. Nature. 527, 249-253 (2015).
190. Liu Y, et al. Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity. Nat. Med. 19, 1173-1177 (2013).
191. Bandukwala H. S, et al. Selective inhibition of CD4+ T cell cytokine production and autoimmunity by BET protein and c Myc inhibitors. Proc. Natl Acad. Sci. USA. 109, 14532-14537 (2012).
192. Fu W, et al. Epigenetic modulation of type 1 diabetes via a dual effect on pancreatic macrophages and β cells. eLife 3, e04631 (2014).
193. Tsuji M, et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science. 323, 1488-1492 (2009).
194. Sharma M. D, et al. An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor Eos. Immunity. 38, 998-1012 (2013).
195. Neumann C, et al. Role of Blimp 1 in programing Th effector cells into IL 10 producers. J. Exp. Med. 211, 1807-1819 (2014).
196. Esplugues E, et al. Control of TH17 cells occurs in the small intestine. Nature. 475, 514-518 (2011).
197. Califano D, et al. Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis. J. Clin. Invest. 124, 174-187 (2013).
198. Heinemann C, et al. IL 27 and IL 12 oppose pro-inflammatory IL 23 in CD4+ T cells by inducing Blimp1. Nat. Commun. 5, 1-13 (2014).
199. Umetsu D. T, et al. Functional heterogeneity among human inducer T cell clones. J. Immunol. 140, 4211-4216 (1988).
200. Maggi E, et al. Profiles of lymphokine activities and helper function for IgE in human T cell clones. Eur. J. Immunol. 18, 1045-1050 (1988).
201. Murphy E, et al. Reversibility of T helper 1 and 2 populations is lost after long-Term stimulation. J. Exp. Med. 183, 901-913 (1996).
202. Komatsu N, et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl Acad. Sci. USA. 106, 1903-1908 (2009).
203. Duarte J. H., Zelenay S., Bergman M. L., Martins A. C, & Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur. J. Immunol. 39, 948-955 (2009).